BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15224305)

  • 21. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
    Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
    Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preconditioning, postconditioning and their application to clinical cardiology.
    Kloner RA; Rezkalla SH
    Cardiovasc Res; 2006 May; 70(2):297-307. PubMed ID: 16516180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Percutaneous coronary interventions in elderly patients: clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study].
    Bossi I; Piccaluga E; Scatturin M; Corvaja N; Pasquetto G; Steffanon L; Oberhollenzer R; Colombo P; Bolognese L; Savonitto S
    G Ital Cardiol (Rome); 2006 Feb; 7(2):136-44. PubMed ID: 16532725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance.
    Werner GS; Fritzenwanger M; Prochnau D; Schwarz G; Ferrari M; Aarnoudse W; Pijls NH; Figulla HR
    J Am Coll Cardiol; 2006 Jul; 48(1):51-8. PubMed ID: 16814648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No-reflow phenomenon and prognosis in patients with acute myocardial infarction.
    Ito H
    Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):499-506. PubMed ID: 16932767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.
    Lee CH; Wong HB; Tan HC; Zhang JJ; Teo SG; Ong HY; Low A; Sutandar A; Lim YT
    J Interv Cardiol; 2005 Aug; 18(4):261-6. PubMed ID: 16115155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reprogramming the cell cycle machinery to treat cardiovascular disease.
    Bicknell KA; Brooks G
    Curr Opin Pharmacol; 2008 Apr; 8(2):193-201. PubMed ID: 18243794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.
    Wang HJ; Lo PH; Lin JJ; Lee H; Hung JS
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):171-6. PubMed ID: 15390241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct demonstration by transthoracic Doppler echocardiography of adenosine-induced coronary steal in the collateral-dependent vessel.
    Takeuchi M; Yoshitani H; Otani S; Yoshikawa J
    Am J Cardiol; 2005 Jun; 95(11):1363-6. PubMed ID: 15904645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary flow reserve assessment by transthoracic color Doppler echocardiography after primary angioplasty: relationship with recovery of left ventricular function].
    Pezzano A; Valentini M; Comerio G; Tavanelli M; Racca V; Brambilla G; Ferratini M
    Ital Heart J Suppl; 2005 Oct; 6(10):660-6. PubMed ID: 16273753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
    De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
    Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of fractional and coronary flow reserve in predicting myocardial recovery in patients with previous myocardial infarction.
    Beleslin B; Ostojic M; Djordjevic-Dikic A; Vukcevic V; Stojkovic S; Nedeljkovic M; Stankovic G; Orlic D; Milic N; Stepanovic J; Giga V; Saponjski J
    Eur Heart J; 2008 Nov; 29(21):2617-24. PubMed ID: 18826987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical thrombectomy options in complex percutaneous coronary interventions.
    Kelly RV; Cohen MG; Stouffer GA
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):917-28. PubMed ID: 17086518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.
    Niccoli G; Lanza GA; Spaziani C; Altamura L; Romagnoli E; Leone AM; Fusco B; Trani C; Burzotta F; Mazzari MA; Mongiardo R; Biasucci LM; Rebuzzi AG; Crea F
    Int J Cardiol; 2007 May; 117(3):306-11. PubMed ID: 16859772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should we revascularize patients with moderate coronary lesions and borderline fractional flow reserve measurements?
    Zijlstra F
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):549-50. PubMed ID: 18307225
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of Danshen.
    Cheng TO
    Int J Cardiol; 2007 Sep; 121(1):9-22. PubMed ID: 17363091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.